Trial Profile
A retrospective study to evaluate treatment response by large-scale radiomic profiling
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Nov 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 19 Nov 2016 New trial record
- 10 Oct 2016 Results published in the Clinical cancer research: an official journal of the American Association for Cancer Research